SCHEMBL20176818

SCHEMBL20176818

C=C(C)/C(C#N)=C/N(C)C

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP2C9 P11712 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.35
NPC1 O15118 2/20 0.33
NPSR1 Q6W5P4 2/20 0.31
HPGD P15428 3/20 0.31
MAPT P10636 2/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1579883 0.76 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL1579880 0.76 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL1579884 0.76 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL13826561 0.76 RAB9A (0.43) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL24135270 0.74 RAB9A (0.46) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL22311522 0.74
SCHEMBL25454067 0.74
SCHEMBL20551511 0.71 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL8412940 0.71 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1
SCHEMBL9449589 0.71 CYP2C9 (0.55) RAB9AKMT2ASMN1; SMN2CYP2C9L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018093569-A1 SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-24 WO disclosed